BCAB · BioAtla, Inc.
$3.09
-0.36 (-10.43%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current operating plan, and along with our history of operating losses, our current cash and cash equivalents are not sufficient to fund our ongoing operations for a period of at least twelve months from the date the condensed consolidated financial statements included in this report are issued, and these circumstances raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$5.15M
Shares
1.67M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BCAB
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 6,128 | $24,083 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 1,610 | $6,327 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 1,456 | $5,722 | 0.00% | Long | 2026-05-31 | |
| Principal Healthcare Innovators ETF | BCHP | 3,004 | $4,115 | 0.03% | Long | 2024-06-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 165 | $648 | 0.00% | Long | 2026-05-31 | |
| Guggenheim Active Allocation Fund | GUG | 1 | $4 | 0.00% | Long | 2026-05-29 |
Showing 1–6 of 6 positions
Key facts
CIK
1826892
CUSIP
09077B203
13F (30d)
21 filings
21 filers
Visit website
Investor relations